scispace - formally typeset
L

Luisa M. Ostertag

Researcher at University of East Anglia

Publications -  5
Citations -  422

Luisa M. Ostertag is an academic researcher from University of East Anglia. The author has contributed to research in topics: Hesperidin & Flavanone. The author has an hindex of 4, co-authored 5 publications receiving 351 citations.

Papers
More filters
Journal ArticleDOI

Cranberries and Their Bioactive Constituents in Human Health

TL;DR: Evidence suggesting that cranberries may decrease the recurrence of urinary tract infections is important because a nutritional approach to this condition could lower the use of antibiotic treatment and the consequent development of resistance to these drugs.
Journal ArticleDOI

Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial

TL;DR: The data suggest that the EP phenotype is critical in unlocking the vascular benefits of equol in men, and long-term trials should focus on confirming the implications of EP phenotype on cardiovascular health.
Journal ArticleDOI

Orange juice–derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease

TL;DR: In this article, the effects of orange juice or a dose-matched hesperidin supplement on plasma concentrations of established and novel flavanone metabolites and their effects on cardiovascular risk biomarkers in men at moderate CVD risk were examined.
Journal ArticleDOI

Genetic and phenotypic determinants of flavonoid absorption and metabolism: the COB study

TL;DR: The COB (Chocolate, Orange and Blackberry) study is examining the influence of genotype, age, gender and composition of the intestinal microbiota on the absorption, metabolism and elimination (AME) of flavonoids.

Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of

TL;DR: Longer-duration randomized controlled trials are required to examine previous associations between higher flavanone intakes and improved cardiovascular health and to ascertain the relative importance of food matrix and Flavanone-derived phenolic metabolites.